[
    [
        {
            "time": "2020-12-17",
            "original_text": "复星医药（02196.HK）：类风湿关节炎（RA）治疗药品利妥昔单抗注射液获药品注册申请受理",
            "features": {
                "keywords": [
                    "复星医药",
                    "利妥昔单抗",
                    "药品注册",
                    "类风湿关节炎"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "复星医药（02196.HK）：类风湿关节炎（RA）治疗药品利妥昔单抗注射液获药品注册申请受理",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-12-17",
            "original_text": "瑞信：复星医药目标价升9.3%至47港元，跑赢大市评级",
            "features": {
                "keywords": [
                    "瑞信",
                    "复星医药",
                    "目标价",
                    "上调",
                    "跑赢大市"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "瑞信：复星医药目标价升9.3%至47港元，跑赢大市评级",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-12-17",
            "original_text": "重磅官宣！我国5支新冠疫苗冲刺中，相关产业链公司即将迎来爆发期",
            "features": {
                "keywords": [
                    "新冠疫苗",
                    "冲刺",
                    "产业链",
                    "爆发期"
                ],
                "sentiment_score": 0.95,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "重磅官宣！我国5支新冠疫苗冲刺中，相关产业链公司即将迎来爆发期",
                "Correlation": 5,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-12-17",
            "original_text": "A股融资融券日报：两融余额增加21.56亿元",
            "features": {
                "keywords": [
                    "A股",
                    "融资融券",
                    "两融余额",
                    "增加"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "整体市场"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "A股融资融券日报：两融余额增加21.56亿元",
                "Correlation": 3,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 5,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-12-17",
            "original_text": "港股盘前必读：复星医药与BioNTech及其控股子公司签订mRNA新冠疫苗供货协议",
            "features": {
                "keywords": [
                    "复星医药",
                    "BioNTech",
                    "mRNA疫苗",
                    "供货协议"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "港股盘前必读：复星医药与BioNTech及其控股子公司签订mRNA新冠疫苗供货协议",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        }
    ]
]